92 related articles for article (PubMed ID: 16514075)
1. TRP proteins: a new dimension in the treatment of occlusive vascular disease.
van Breemen C; Poburko D; Okon EB
Circ Res; 2006 Mar; 98(4):446-7. PubMed ID: 16514075
[No Abstract] [Full Text] [Related]
2. Upregulated TRPC1 channel in vascular injury in vivo and its role in human neointimal hyperplasia.
Kumar B; Dreja K; Shah SS; Cheong A; Xu SZ; Sukumar P; Naylor J; Forte A; Cipollaro M; McHugh D; Kingston PA; Heagerty AM; Munsch CM; Bergdahl A; Hultgårdh-Nilsson A; Gomez MF; Porter KE; Hellstrand P; Beech DJ
Circ Res; 2006 Mar; 98(4):557-63. PubMed ID: 16439693
[TBL] [Abstract][Full Text] [Related]
3. A key role of TRPC channels in the regulation of electromechanical activity of the developing heart.
Sabourin J; Robin E; Raddatz E
Cardiovasc Res; 2011 Nov; 92(2):226-36. PubMed ID: 21672930
[TBL] [Abstract][Full Text] [Related]
4. [TRP channels as targets for novel calcium antagonists].
Kiyonaka S; Mori Y
Nihon Yakurigaku Zasshi; 2005 Nov; 126(5):317-20, 328. PubMed ID: 16394575
[No Abstract] [Full Text] [Related]
5. The sinoatrial node is still setting the pace 100 years after its discovery.
Boyett MR; Dobrzynski H
Circ Res; 2007 Jun; 100(11):1543-5. PubMed ID: 17556667
[No Abstract] [Full Text] [Related]
6. TRP channels in disease.
Nilius B; Voets T; Peters J
Sci STKE; 2005 Aug; 2005(295):re8. PubMed ID: 16077087
[TBL] [Abstract][Full Text] [Related]
7. [New frontier for the pathophysiology of TRP channels in cardiovascular system: cardiovascular remodeling and TRP channels].
Inoue R; Honda A; Lin H
Tanpakushitsu Kakusan Koso; 2008 Jun; 53(7):844-53. PubMed ID: 18536347
[No Abstract] [Full Text] [Related]
8. Recent developments in vascular endothelial cell transient receptor potential channels.
Yao X; Garland CJ
Circ Res; 2005 Oct; 97(9):853-63. PubMed ID: 16254217
[TBL] [Abstract][Full Text] [Related]
9. Phospholipase C-coupled receptors and activation of TRPC channels.
Trebak M; Lemonnier L; Smyth JT; Vazquez G; Putney JW
Handb Exp Pharmacol; 2007; (179):593-614. PubMed ID: 17217081
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the antiatherosclerotic effects of dihydropyridine calcium channel blocker and HMG-CoA reductase inhibitor on hypercholesterolemic rabbits.
Takayama M; Matsubara M; Arakawa E; Takada C; Ina Y; Hasegawa K; Yao K
Vascul Pharmacol; 2007 Apr; 46(4):302-8. PubMed ID: 17197250
[TBL] [Abstract][Full Text] [Related]
11. [Renal protective action of T-, L-, and N-type Ca channel blockers].
Hayashi K
Nihon Rinsho; 2004 Mar; 62 Suppl 3():654-61. PubMed ID: 15171451
[No Abstract] [Full Text] [Related]
12. TRP channels as drug targets.
Li S; Westwick J; Cox B; Poll CT
Novartis Found Symp; 2004; 258():204-13; discussion 213-21, 263-6. PubMed ID: 15104184
[TBL] [Abstract][Full Text] [Related]
13. TRPC channels determine human keratinocyte differentiation: new insight into basal cell carcinoma.
Beck B; Lehen'kyi V; Roudbaraki M; Flourakis M; Charveron M; Bordat P; Polakowska R; Prevarskaya N; Skryma R
Cell Calcium; 2008 May; 43(5):492-505. PubMed ID: 17920677
[TBL] [Abstract][Full Text] [Related]
14. Calcium antagonists in hypertensive disease: experimental evidence for a new therapeutic concept.
Kazda S; Garthoff B; Luckhaus G
Postgrad Med J; 1983; 59 Suppl 2():78-83. PubMed ID: 6351044
[TBL] [Abstract][Full Text] [Related]
15. Impact of converting enzyme inhibitors and calcium entry blockers on cardiac allograft vasculopathy: from bench to bedside.
Mehra MR; Ventura HO; Smart FW; Stapleton DD
J Heart Lung Transplant; 1995; 14(6 Pt 2):S246-9. PubMed ID: 8719495
[No Abstract] [Full Text] [Related]
16. [Calcium antagonists in heart-circulatory therapy].
Hollenhorst W
Med Monatsschr Pharm; 1984 Jul; 7(7):209-11. PubMed ID: 6482828
[No Abstract] [Full Text] [Related]
17. Dihydropyridines and vascular diseases.
Tamargo J; Delpón E
Z Kardiol; 1991; 80 Suppl 7():106-11. PubMed ID: 1792815
[TBL] [Abstract][Full Text] [Related]
18. Blocking potassium channels: a new principle for treating restenosis?
Olschewski A
Cardiovasc Res; 2011 Feb; 89(2):255-7. PubMed ID: 21156820
[No Abstract] [Full Text] [Related]
19. Ca2+ channel subtypes and pharmacology in the kidney.
Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
[TBL] [Abstract][Full Text] [Related]
20. Molecular determinants of TRP channel assembly.
Lepage PK; Boulay G
Biochem Soc Trans; 2007 Feb; 35(Pt 1):81-3. PubMed ID: 17233606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
